Novartis drug data meddling clouds Japan's clinical studies

National Oct 3, 2013

Novartis drug data meddling clouds Japan's clinical studies

A health ministry panel is questioning Novartis Pharma K.K.'s use of clinical research data in promoting the sale of Diovan, its drug to lower blood pressure, saying it "could constitute misleading advertisement" after revelations that some of the data were manipulated. The Japanese unit of ...

Editorials Jul 28, 2013

Question of objectivity

A Kyoto university's announcement that research on blood-pressure drug Diovan was manipulated raises concerns about the drugmaker's objectivity.